Lexaria Bioscience Corp.: Lexaria Grants License to AnodGen

DehydraTECH Pharmaceutical License Issued for the European, Australian and New Zealand marketsLexaria to receive royalty revenue from DehydraTECH product salesKELOWNA, BC / ACCESSWIRE / June 8, 2022 /

Related Keywords

Australia , New Zealand , Ireland , United Kingdom , Australian , Andogen Bioceuticals , George Jurcic , Anodgen Bioceuticals , Jeffrey Pruski , Slimane Aboulkacem , Exchange Commission , Lexaria Pharmaceutical Corp , Lexaria Bioscience Corp , Company Or Lexaria , Drug Administration , Nasdaq , License Issued , Lexaria Bioscience , Lexaria Pharmaceutical , Bring Science , Founding Member , Chief Medical Officer , Lexaria , Ioscience , Orp , Migrants , License , Nodgen , Ioceuticals ,